InsiderClue
Stocks · Health care · Pharmaceutical Preparations

KAZIA THERAPEUTICS LTD

KZIA Clue Score12
Australia Fiscal year ends June CIK 0001075880
$8.93 +1.25% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.93 −15.19% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 24 Nov 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2017Revenue0.2Net income−10.7EPS, diluted−2.28Fiscal year 2018Revenue0.1 −52.2%Net income−6.0EPS, diluted−12.48Fiscal year 2019Net income−10.3EPS, diluted−17.86Fiscal year 2020Net income−12.5EPS, diluted−0.17Fiscal year 2021Revenue15.2Net income−8.4EPS, diluted−0.07Fiscal year 2022Revenue0.0 −100.0%Net income−25.0EPS, diluted−0.19Fiscal year 2023Revenue0.0Net income−20.5EPS, diluted−0.11Fiscal year 2024Revenue2.3Net income−26.8EPS, diluted−0.10Fiscal year 2025Revenue0.0 −98.2%Net income−20.7EPS, diluted−0.04
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.1 n/a n/a 15.2 0.0 0.0 2.3 0.0
Growth −52.2% −100.0% −98.2%
Net income −10.7 −6.0 −10.3 −12.5 −8.4 −25.0 −20.5 −26.8 −20.7
Growth
EPS, diluted −2.28 −12.48 −17.86 −0.17 −0.07 −0.19 −0.11 −0.10 −0.04

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2017Net margin−4,285.1%Free cash flow margin−4,597.2%Fiscal year 2018Net margin−5,074.8%Fiscal year 2019Fiscal year 2020Fiscal year 2021Net margin−55.5%Fiscal year 2022Fiscal year 2023Fiscal year 2024Net margin−1,160.2%Fiscal year 2025Net margin−49,290.5%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin −4,285.1% −5,074.8% n/a n/a −55.5% n/a n/a −1,160.2% −49,290.5%
Free cash flow margin −4,597.2% n/a n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−11.4Capital expenditure−0.0Free cash flow−11.4Dividends paid0.0Fiscal year 2018Operating cash flow−8.7Dividends paid0.0Fiscal year 2019Operating cash flow−6.7Dividends paid0.0Fiscal year 2020Operating cash flow−8.8Fiscal year 2021Operating cash flow−9.1Fiscal year 2022Operating cash flow−22.8Fiscal year 2023Operating cash flow−15.2Dividends paid0.0Fiscal year 2024Operating cash flow−9.6Dividends paid0.0Fiscal year 2025Operating cash flow−13.3Dividends paid0.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −11.4 −8.7 −6.7 −8.8 −9.1 −22.8 −15.2 −9.6 −13.3
Capital expenditure −0.0 n/a n/a n/a n/a n/a n/a n/a n/a
Free cash flow −11.4 n/a n/a n/a n/a n/a n/a n/a n/a
Growth
Dividends paid 0.0 0.0 0.0 n/a n/a n/a 0.0 0.0 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash14.5Shareholders’ equity25.3Fiscal year 2018Cash6.0Shareholders’ equity19.2Fiscal year 2019Cash5.4Shareholders’ equity14.2Fiscal year 2020Cash8.8Shareholders’ equity14.1Fiscal year 2021Cash27.6Shareholders’ equity37.9Fiscal year 2022Cash7.4Shareholders’ equity18.3Fiscal year 2023Cash5.2Shareholders’ equity12.1Fiscal year 2024Cash1.7Shareholders’ equity−10.0Fiscal year 2025Cash4.3Shareholders’ equity−8.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 14.5 6.0 5.4 8.8 27.6 7.4 5.2 1.7 4.3
Shareholders’ equity 25.3 19.2 14.2 14.1 37.9 18.3 12.1 −10.0 −8.3

In millions of AUD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of AUD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018† 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021† 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025† 30 Jun 2025
Revenue and profit
0.2 0.1 n/a n/a 15.2 0.0 0.0 2.3 0.0
Growth −52.2% −100.0% −98.2%
11.1 9.8 6.5 9.5 14.5 20.2 15.6 17.4 7.3
8.5 5.6 3.8 3.7 7.0 5.1 8.6 13.6 8.7
−10.9 −6.3 −10.6 −12.8 −8.9 −25.4 −20.7 −27.0 −22.4
−0.2 −0.3 −0.3 −0.3 −0.5 −0.4 −0.3 −0.3 −1.7
−10.7 −6.0 −10.3 −12.5 −8.4 −25.0 −20.5 −26.8 −20.7
Growth
Per share
−2.28 −12.48 −17.86 −0.17 −0.07 −0.19 −0.11 −0.10 −0.04
−2.28 −12.48 −17.86 −0.17 −0.07 −0.19 −0.11 −0.10 −0.04
Growth
467.8 48.4 57.5 73.1 117.7 132.5 184.3 n/a n/a
467.8 48.4 57.5 73.1 117.7 132.5 184.3 263.7 547.9
Growth −89.7% +18.9% +27.0% +61.1% +12.6% +39.1% +43.1% +107.8%

† The diluted share count jumps at 2018 and 2021 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Shown in AUD as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 18.8% a year over five years.
  • A net loss in 9 of 9 years on file.